Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-03
2006-10-03
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S254060, C514S234500, C514S338000, C514S278000, C514S322000, C514S316000, C514S211030, C514S365000, C544S370000, C544S139000, C540S524000, C546S273700, C546S199000, C546S187000, C546S017000, C548S306400, C548S304700, C548S181000, C548S306100
Reexamination Certificate
active
07115644
ABSTRACT:
Disclosed are benzimidazolone compounds of formulas (I) & (II):wherein R1, R2, R3, R4, R5, X, L, m, n and t are defined herein. The compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds
REFERENCES:
patent: 5162318 (1992-11-01), Hara et al.
patent: 5200422 (1993-04-01), Olesen et al.
patent: 5281714 (1994-01-01), Fobare et al.
patent: 5371094 (1994-12-01), Heine et al.
patent: 5534534 (1996-07-01), Makino et al.
patent: 6498275 (2002-12-01), Butlin et al.
patent: 2003/0139605 (2003-07-01), Riedl et al.
patent: 0 616 807 (1998-08-01), None
patent: 1036821 (2000-09-01), None
patent: WO 94/05281 (1994-03-01), None
patent: WO 99/62506 (1999-12-01), None
patent: WO 00/41698 (2000-07-01), None
patent: WO 0050419 (2000-08-01), None
patent: WO 01/05770 (2001-01-01), None
Morel et al., Magnetic Resonance in Chemistry (1997), 35(8), pp. 556-560.
Viswanathan et al., Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry (1985), 24B(9), pp. 948-951.
Efros et al., Zhurnal Obshchei Khimii (1957), 27, pp. 127-135.
Chemical Abstracts, Database Accession No. 1997;539019; XP002265898; RN 195379-37-4 & Magnetic Resonance In Chemistry: vol. 35, No. 8, 1997, pp. 556-560.
Barbosa, Jr. Antonio Jose del Moral
Goldberg Daniel R.
Hammach Abdelhakim
Liu Pingrong
Moss Neil
Boehringer Ingelheim Pharmaceuticals Inc.
Bottino Anthony P.
Datlow Philip I.
Morris Michael P.
Stockton Laura L.
LandOfFree
Heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3663092